Management of Drug-Resistant Plasmodium vivax and Plasmodium falciparum Malaria in India
Abstract
How to cite this article:
Nath A. Management of Drug-Resistant Plasmodium vivax and Plasmodium falciparum Malaria in India. Special Issue - COVID-19 & Other Communicable Disease. 2022;1-2.
References
Directorate of National Vector Borne Disease Control Programme, 2016 [Internet]. National Framework for Malaria Elimination in India 2016–2030. Directorate General of Health Services Ministry of Health and Family Welfare, Government of India: New Delhi, India; 2016. p. 1-43. Available from: https://nvbdcp.gov.in/WriteReadData/l892s/National-framework-for-malaria-elimination-in-India-2016%E2%80%932030.pdf
World Health Organization [Internet]. Global technical strategy for malaria 2016–2030. Available from: https://www.who.int/publications/i/item/9789240031357 [Google Scholar]
Government of India [Internet]. Annual Report of National Vector-Borne Disease Control Programme 2018. Available from: https://nvbdcp.gov.in/Doc/Annual-Report-2018.pdf
Government of India [Internet]. National Drug Policy on Malaria 2013. Available from: https://nvbdcp.gov.in/WriteReadData/l892s/National-Drug-Policy-2013.pdf
Bassat Q. The use of arthemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria. PLoS Negl Trop Dis. 2011 Dec;5(12):e1325. [PubMed] [Google Scholar]
Copyright (c) 2022 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
